Patents

11- Weiping Wang, Kaiqi Long, Yifan Wang, Photocleavable prodrug-based nanomedicine for in-situ monitorable cancer therapy, US Provisional Patent (No. 63/262,789, 2021)

10- Weiping Wang, Yuwei Liu, Kaiqi Long, Photoresponsive prodrugs for targeted immunotherapy, US Provisional Patent (No. 63/203,687, 2021)

9-   Weiping Wang, Kaiqi Long, Shuting Xu, Photoactivatable prodrug nanoparticles for combined anti-angiogenesis and photodynamic therapy, PCT Patent (No. PCT/CN2022/107621, 2022)

8-   Weiping Wang, Yaming Zhang, ROS-responsive prodrugs and compositions and methods of thereof, PCT Patent (No. PCT/CN2022/104160, 2022)

7-   Weiping Wang, Tianyi Wang, Kaiqi Long, Compositions and Methods of optochemical control of mTOR signaling and mTOR-dependent autophagy, Chinese Patent (No. 202210749138.6, 2022), US Patent (No. 17/850,720, 2022)

6-   Weiping Wang, Yang Zhou, Yafei Li, A photoresponsive delivery system based on a modified PAMAM and methods thereof, PCT Patent (No. PCT/CN2022/097804, 2022)

5-   Weiping Wang, Yafei Li, Compositions and methods of macropinocytosis inhibitors to treat cancers, PCT Patent (No.PCT/CN2022/092398, 2022)

4-   Weiping Wang, Kaiqi Long, A controlled drug release system of photoresponsive nanocarriers, methods of making and using thereof, PCT Patent (No. PCT/CN2021/081262, 2021)

3-   Weiping Wang, Wen Lyv, Triplet-triplet energy transfer with light excitation at long wavelengths and methods thereof, PCT Patent (No. PCT/CN2019/101689, 2019), Chinese Patent (No. 201980054786.6, 2021), US Patent (No. 17/262,452, 2021).

2-   Daniel S. Kohane, Weiping Wang, Qian Liu, Triplet-triplet annihilation-based upconversion, PCT Patent (No. PCT/US2016/040271, 2016), US Patent (No. 15/740,396, 2018)

1-  Long-Ping Wen, Yongping Chen, Xin Guo, Yuanyuan Shen, Weiping Wang, Brian Zhang, Transdermal delivery peptides and method of use thereof, US Patent (No. US11/531,879, 2006)